{"nct_id":"NCT04892472","title":"EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer","status":"TERMINATED","status_verified_date":"2025-04","start_date":"2021-07-12","start_date_type":"ACTUAL","primary_completion_date":"2025-01-10","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVCR"]}